A cell-free biosynthesis platform for modular construction of protein glycosylation pathways
Authors:
- Weston KightlingerWKWeston Kightlinger
- Katherine E. DunckerKDKatherine E. Duncker
- Ashvita RameshARAshvita Ramesh
- Ariel H. ThamesATAriel H. Thames
- Aravind NatarajanANAravind Natarajan
- Allen YangAYAllen Yang
- Jessica C. StarkJSJessica C. Stark
- Liang LinLLLiang Lin
- Milan MrksichMMMilan Mrksich
- Matthew P. DeLisaMatthew P. DeLisa
- Michael C. JewettMJMichael C. Jewett
Preprint
Abstract
Glycosylation plays important roles in cellular function and endows protein therapeutics with beneficial properties. However, constructing biosynthetic pathways to study and engineer protein glycosylation remains a bottleneck. To address this limitation, we describe a modular, versatile cell-free platform for glyco sylation p athway assembly by rapid in vitro m ixing and e xpression (GlycoPRIME). In GlycoPRIME, crude cell lysates are enriched with glycosyltransferases by cell-free protein synthesis and then glycosylation pathways are assembled in a mix-and-match fashion to elaborate a single glucose priming handle installed by an N -linked glycosyltransferase. We demonstrate GlycoPRIME by constructing 37 putative protein glycosylation pathways, creating 23 unique glycan motifs. We then use selected pathways to design a one-pot cell-free system to synthesize a vaccine protein with an α-galactose motif and engineered Escherichia coli strains to produce human antibody constant regions with minimal sialic acid motifs. We anticipate that our work will facilitate glycoscience and make possible new glycoengineering applications.Keywords
All Related Versions
- Published version: Nature Communications, 10 (1), 1.
This publication has 89 references indexed in Scilit:
- Discovery of glycosyltransferases using carbohydrate arrays and mass spectrometryNature Chemical Biology, 2012
- An engineered eukaryotic protein glycosylation pathway in Escherichia coliNature Chemical Biology, 2012
- Cytoplasmic N-Glycosyltransferase of Actinobacillus pleuropneumoniae Is an Inverting Enzyme and Recognizes the NX(S/T) Consensus SequenceJournal of Biological Chemistry, 2011
- Exploiting Bacterial Glycosylation Machineries for the Synthesis of a Lewis Antigen-containing GlycoproteinJournal of Biological Chemistry, 2011
- Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot databaseScientific Reports, 2011
- Site-specific enzymatic polysialylation of therapeutic proteins using bacterial enzymesProceedings of the National Academy of Sciences, 2011
- Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing α-gal epitopesVaccine, 2010
- Sialic acids in human health and diseaseTrends in Molecular Medicine, 2008
- Construction of Escherichia coli K‐12 in‐frame, single‐gene knockout mutants: the Keio collectionMolecular Systems Biology, 2006
- Enhancement of therapeutic protein in vivo activities through glycoengineeringNature Biotechnology, 2003